Showing results (1071-1080 of 2,284) with videos related to
Sort By:
Pageof 229
HIV Medicine|May 1, 2024
Prevalence of people living with multidrug-resistant HIV and limited treatment options in SpainJosep M Llibre, Federico García, José Luis Blanco, et al.HIV Medicine|May 15, 2024
Mpox in people with HIV: A narrative reviewHideta Nakamura, Kazuko YamamotoHIV Medicine|April 21, 2024
Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS)M John, L Williams, G Nolan, et al.HIV Medicine|January 25, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohortJesús Troya, Rafael Mican, María José Galindo, et al.HIV Medicine|December 12, 2025
Late diagnosis of paediatric HIV infection in high-income countries: Lessons from the HIV Perinatal Virtual ClinicCarolina Curto, M Tritzali, A Bamford, et al.HIV Medicine|December 9, 2025
TelePrEP in Italy: A remote service to expand equitable access to HIV pre-exposure prophylaxisMaria Luisa Cosmaro, Sabrina Penon, Francesco Falzetta, et al.HIV Medicine|November 22, 2025
Barriers and mitigating strategies to routine HIV screening in emergency departments: A national qualitative studyStefanie S Sebok-Syer, Abigail R Tapper, Melissa A Pasao, et al.HIV Medicine|November 18, 2025
Anal cancer screening in men who have sex with men living with HIV: The pilot of anal screening study (PASS)Clare E F Dyer, Fengyi Jin, Jennifer M Roberts, et al.HIV Medicine|January 15, 2025
Intracellular tenofovir-diphosphate concentrations in HIV pre-exposure prophylaxis users who underwent bariatric surgeryMatthew W McGarrity, Paul MacPherson, Abby Li, et al.HIV Medicine|January 3, 2025
Transitions in treatment: A systematic review and meta-aggregation of preferences and barriers in switching from oral to long-acting injectable antiretroviral therapy among people living with HIV and stakeholdersTiantian Hu, Shuqi Yang, Junwen Yu, et al.Pageof 229